Abstract

Bladder cancer (BC) is among the most common malignancies in the world and a relevant cause of cancer mortality. BC is one of the most frequent causes for bladder removal through radical cystectomy, the gold-standard treatment for localized muscle-invasive and some cases of high-risk, non-muscle-invasive bladder cancer. In order to restore urinary functionality, an autologous intestinal segment has to be used to create a urinary diversion. However, several complications are associated with bowel-tract removal, affecting patients’ quality of life. The present study project aims to develop a bio-engineered material to simplify this surgical procedure, avoiding related surgical complications and improving patients’ quality of life. The main novelty of such a therapeutic approach is the decellularization of a porcine small intestinal submucosa (SIS) conduit to replace the autologous intestinal segment currently used as urinary diversion after radical cystectomy, while avoiding an immune rejection. Here, we performed a preliminary evaluation of this acellular product by developing a novel decellularization process based on an environmentally friendly, mild detergent, i.e., Tergitol, to replace the recently declared toxic Triton X-100. Treatment efficacy was evaluated through histology, DNA, hydroxyproline and elastin quantification, mechanical and insufflation tests, two-photon microscopy, FTIR analysis, and cytocompatibility tests. The optimized decellularization protocol is effective in removing cells, including DNA content, from the porcine SIS, while preserving the integrity of the extracellular matrix despite an increase in stiffness. An effective sterilization protocol was found, and cytocompatibility of treated SIS was demonstrated from day 1 to day 7, during which human fibroblasts were able to increase in number and strongly organize along tissue fibres. Taken together, this in vitro study suggests that SIS is a suitable candidate for use in urinary diversions in place of autologous intestinal segments, considering the optimal results of decellularization and cell proliferation. Further efforts should be undertaken in order to improve SIS conduit patency and impermeability to realize a future viable substitute.

Highlights

  • Bladder cancer is among the most common malignancies in the world (10th in rank) and at an almost-similar level as a cause of mortality [1]

  • The DNA content in the decellularized small intestinal submucosa (SIS) was below the threshold of 50 ng dsDNA/mg dry tissue, which is stated as a criterion for successful decellularization [51]

  • We observed a significant increase in second harmonic generation (SHG) intensity following the decellularization process due to a denser distribution of collagen fibres in decellularized tissue

Read more

Summary

Introduction

Bladder cancer is among the most common malignancies in the world (10th in rank) and at an almost-similar level as a cause of mortality [1]. There is an increasing demand for an alternative urinary conduit after radical cystectomy, which can be represented by tissue-engineered urinary conduits instead of autologous intestine. This approach is intended to largely improve the surgical procedure, limiting its duration and reducing possible intra-operatory risks, but it can decrease patients’ post-operative complications (e.g., stone formation, recurrent urinary tract infections, uretero-enteric strictures, renal function deterioration, and incontinence) [8,9]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call